Francesca Barone Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Francesca Barone is Chief Scientific Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 159,961 shares of CADL, which is worth approximately $1.15 Million. The most recent transaction as insider was on Jul 17, 2024, when has been sold 14,051 shares (Common Stock) at a price of $6.47 per share, resulting in proceeds of $90,909. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 160K
14.3% 3M change
5742.26% 12M change
Total Value Held $1.15 Million

Francesca Barone Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2024
SELL
Open market or private sale
$90,909 $6.47 p/Share
14,051 Reduced 8.07%
159,961 Common Stock
Jul 11 2024
SELL
Open market or private sale
$75,490 $5.97 p/Share
12,645 Reduced 6.77%
174,012 Common Stock
Nov 28 2023
SELL
Payment of exercise price or tax liability
$17,773 $0.9 p/Share
19,748 Reduced 9.57%
186,657 Common Stock
Nov 26 2023
BUY
Grant, award, or other acquisition
-
112,790 Added 35.34%
206,405 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$1,993 $1.61 p/Share
1,238 Added 31.14%
2,738 Common Stock
Nov 28 2022
BUY
Grant, award, or other acquisition
-
90,877 Added 49.59%
92,377 Common Stock
FB

Francesca Barone

Chief Scientific Officer
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL